If You Invested $1000 in Idexx Laboratories a Decade Ago, This is How Much It'd Be Worth Now
For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and industries.
Another thing that can drive investing is the fear of missing out, or FOMO. This particularly applies to tech giants and popular consumer-facing stocks.
What if you'd invested in Idexx Laboratories (IDXX) ten years ago? It may not have been easy to hold on to IDXX for all that time, but if you did, how much would your investment be worth today?
With that in mind, let's take a look at Idexx Laboratories' main business drivers.
Headquartered in Westbrook, ME, IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.IDEXX operates through four segments:Companion Animal Group (CAG) (91.7% of revenues in 2024, up 1.0% from 2023): This segment provides veterinarians with diagnostic capabilities and information management solutions that enhance the health and well-being of pets. The complementary nature of these products and services provides a unique competitive advantage known as the IDEXX Diagnostic Advantage, providing vets with the tools and services necessary to offer advanced veterinary medical care.Water (4.7%, up 2.2%): Through this segment, IDEXX provides innovative testing solutions for easy, rapid and accurate detection and quantification of various microbiological parameters in water, helping ensure water safety for people worldwide.Livestock, Poultry and Dairy (LPD) (3.1%, down 6.0%): Within this segment, IDEXX provides diagnostic tests and related instrumentation required to manage the health status of livestock and poultry to improve bovine reproductive efficiency and ensure the quality and safety of milk and food. These products are purchased by the government and private laboratories that provide testing services to cattle, swine and poultry veterinarians, producers and processors.Other (0.4%, down 20.0%): The company's OPTI Medical operating segment has been combined and presented with the remaining pharmaceutical product line and the out-licensing arrangements in an 'Other' category, primarily because they do not meet the quantitative or qualitative thresholds for reportable segments.
While anyone can invest, building a lucrative investment portfolio takes research, patience, and a little bit of risk. If you had invested in Idexx Laboratories ten years ago, you're probably feeling pretty good about your investment today.
According to our calculations, a $1000 investment made in May 2015 would be worth $7,661.93, or a 666.19% gain, as of May 19, 2025. Investors should keep in mind that this return excludes dividends but includes price appreciation.
The S&P 500 rose 180.69% and the price of gold increased 153.90% over the same time frame in comparison.
Analysts are anticipating more upside for IDXX.
IDEXX's robust strategic execution is highlighted by new business gains, high customer retention levels and solid net price realization. This underscores the consistent growth in the CAG international business, supported by volume gains and global premium instrument placements. The company's software solutions are facilitating growth by enhancing clinic workflows and promoting greater utilization of diagnostics. Also, the consumable business boosts its top line. Meanwhile, IDEXX's debt-burdened balance sheet raises concern. The company's wide global presence makes it vulnerable to currency fluctuations. Meanwhile, broader macroeconomic issues are slowing its operations.
The stock has jumped 25.91% over the past four weeks. Additionally, no earnings estimate has gone lower in the past two months, compared to 7 higher, for fiscal 2025; the consensus estimate has moved up as well.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
IDEXX Laboratories, Inc. (IDXX) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
an hour ago
- USA Today
Investors brace for oil price spike, rush to havens after US bombs Iran nuclear sites
NEW YORK - A U.S. attack on Iranian nuclear sites on Saturday could lead to a knee-jerk reaction in global markets when they reopen, sending oil prices higher and triggering a rush to safety, investors said, as they assessed how the latest escalation of tensions would ripple through the global economy. The attack, which was announced by President Donald Trump on social media site Truth Social, deepens U.S. involvement in the Middle East conflict. That was the question going into the weekend, when investors were mulling a host of different market scenarios. In the immediate aftermath of the announcement, they expected the U.S. involvement was likely to cause a selloff in equities and a possible bid for the dollar and other safe-haven assets when trading begins, but also said much uncertainty about the course of the conflict remained. Updates: U.S. hits Iran nuclear facilities, braces for counterattack While Trump called the attack "successful", few details were known. He was expected to address the nation later on Saturday. "I think the markets are going to be initially alarmed, and I think oil will open higher," said Mark Spindel, chief investment officer at Potomac River Capital. "We don't have any damage assessment and that will take some time. Even though he has described this as 'done', we're engaged. What comes next?" Spindel said. "I think the uncertainty is going to blanket the markets, as now Americans everywhere are going to be exposed. It's going to raise uncertainty and volatility, particularly in oil," he added. Spindel, however, said there was time to digest the news before markets open and said he was making arrangements to talk to other market participants. How will oil prices and inflation be affected? A key concern for markets would center around the potential impact of the developments in the Middle East on oil prices and thus on inflation. A rise in inflation could dampen consumer confidence and lessen the chance of near-term interest rate cuts. "This adds a complicated new layer of risk that we'll have to consider and pay attention to," said Jack Ablin, chief investment officer of Cresset Capital. "This is definitely going to have an impact on energy prices and potentially on inflation as well." While global benchmark Brent crude futures have risen as much as 18% since June 10, hitting a near five-month high of $79.04 on Thursday, the S&P 500 has been little changed, following an initial drop when Israel launched its attacks on Iran on June 13. Before the U.S. attack on Saturday, analysts at Oxford Economics modeled three scenarios, including a de-escalation of the conflict, a complete shutdown in Iranian oil production and a closure of the Strait of Hormuz, "each with increasingly large impacts on global oil prices." Israel-Iran timeline: How Israeli attack and Iranian retaliation unfolded In the most severe case, global oil prices jump to around $130 per barrel, driving U.S. inflation near 6% by the end of this year, Oxford said in the note. "Although the price shock inevitably dampens consumer spending because of the hit to real incomes, the scale of the rise in inflation and concerns about the potential for second-round inflation effects likely ruin any chance of rate cuts in the U.S. this year," Oxford said in the note, which was published before the U.S. strikes. In comments after the announcement on Saturday, Jamie Cox, managing partner at Harris Financial Group, agreed oil prices would likely spike on the initial news. But Cox said he expected prices to likely level in a few days as the attacks could lead Iran to seek a peace deal with Israel and the United States. "With this demonstration of force and total annihilation of its nuclear capabilities, they've lost all of their leverage and will likely hit the escape button to a peace deal," Cox said. Economists warn that a dramatic rise in oil prices could damage a global economy already strained by Trump's tariffs. Still, any pullback in equities might be fleeting, history suggests. During past prominent instances of Middle East tensions coming to a boil, including the 2003 Iraq invasion and the 2019 attacks on Saudi oil facilities, stocks initially languished but soon recovered to trade higher in the months ahead. On average, the S&P 500 slipped 0.3% in the three weeks following the start of conflict, but was 2.3% higher on average two months following the conflict, according to data from Wedbush Securities and CapIQ Pro. What will this mean for the US dollar? An escalation in the conflict could have mixed implications for the U.S. dollar, which has tumbled this year amid worries over diminished U.S. exceptionalism. In the event of U.S. direct engagement in the Iran-Israel war, the dollar could initially benefit from a safety bid, analysts said. "Do we see a flight to safety? That would signal yields going lower and the dollar getting stronger," said Steve Sosnick, chief market strategist at IBKR in Greenwich, Connecticut. "It's hard to imagine stocks not reacting negatively and the question is how much. It will depend on Iranian reaction and whether oil prices spike." (Reporting by Saqib Iqbal Ahmed, Lewis Krauskopf, Suzanne McGee and Saeed Azhar; Editing by Megan Davies, Diane Craft, Peter Henderson, Marguerita Choy and Jamie Freed)
Yahoo
3 hours ago
- Yahoo
Why Nano Nuclear Energy Stock Was Red-Hot This Week
The nuclear energy sector got a boost from proposed modifications to President Trump's "Big, Beautiful Bill." The segment would receive an extension to the expiration date of key tax credits. 10 stocks we like better than Nano Nuclear Energy › Not for the first time this year, Nano Nuclear Energy (NASDAQ: NNE) stock was going somewhat nuclear over the past few trading sessions. On news that a Senate committee desires changes in President Trump's "Big, Beautiful Bill" that favor the once-struggling industry, interest rose sharply in nuclear stocks. Nano was a direct beneficiary of this; according to data compiled by S&P Global Market Intelligence, its share price had ballooned by nearly 25% week to date as of Friday before market open. The bill is an ambitious budget reconciliation proposal that would reshape the federal budget. Early in the week, one new change floated by the Senate Finance Committee was an adjustment of the tax credits the feds provide to energy producers. Some power-generation technologies currently out of favor with the present administration would have their tax credit expiration dates brought forward, while others would be granted extensions. Happily for Nano investors, nuclear energy is in the latter category. The committee is proposing that nuclear's energy production tax credit, currently set to be phased out on Dec. 31, 2032, have a new expiration date of Dec. 31, 2036. The president has been active in his support for nuclear power, which in the recent past was largely shunned. Its reputational decline was due mostly to high-profile accidents such as the Three Mile Island incident in 1979, and the catastrophic 1986 meltdown of the Chernobyl plant located in Ukraine (then part of the Soviet Union). Despite its very positive-sounding name, the "Big, Beautiful Bill" is controversial and contentious among both legislators and the U.S. public. Given that, it's very possible that it will be hammered out through more compromises -- and these might lead lawmakers to rescind the nuclear tax credit extension idea. Still, the proposal currently on the table at least indicates continued strong, top-level support for nuclear power, and that can only help companies like Nano. Before you buy stock in Nano Nuclear Energy, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Nano Nuclear Energy wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $659,171!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $891,722!* Now, it's worth noting Stock Advisor's total average return is 995% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Nano Nuclear Energy Stock Was Red-Hot This Week was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
7 hours ago
- Yahoo
Datadog (DDOG) Falls More Steeply Than Broader Market: What Investors Need to Know
In the latest close session, Datadog (DDOG) was down 1.95% at $127.50. This change lagged the S&P 500's 0.22% loss on the day. Meanwhile, the Dow experienced a rise of 0.08%, and the technology-dominated Nasdaq saw a decrease of 0.51%. The data analytics and cloud monitoring company's stock has climbed by 12.42% in the past month, exceeding the Computer and Technology sector's gain of 2.98% and the S&P 500's gain of 0.45%. Analysts and investors alike will be keeping a close eye on the performance of Datadog in its upcoming earnings disclosure. On that day, Datadog is projected to report earnings of $0.41 per share, which would represent a year-over-year decline of 4.65%. Our most recent consensus estimate is calling for quarterly revenue of $789.55 million, up 22.36% from the year-ago period. Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $1.69 per share and revenue of $3.23 billion. These totals would mark changes of -7.14% and +20.17%, respectively, from last year. Any recent changes to analyst estimates for Datadog should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the business outlook. Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system. The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 3.1% lower. Datadog is currently sporting a Zacks Rank of #4 (Sell). In terms of valuation, Datadog is currently trading at a Forward P/E ratio of 76.76. This expresses a premium compared to the average Forward P/E of 27.94 of its industry. We can also see that DDOG currently has a PEG ratio of 9.51. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Internet - Software stocks are, on average, holding a PEG ratio of 2.11 based on yesterday's closing prices. The Internet - Software industry is part of the Computer and Technology sector. This industry, currently bearing a Zacks Industry Rank of 52, finds itself in the top 22% echelons of all 250+ industries. The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. To follow DDOG in the coming trading sessions, be sure to utilize Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Datadog, Inc. (DDOG) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
